NEOPLASMS, RECTAL
Clinical trials for NEOPLASMS, RECTAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, RECTAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, RECTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a single drug replace the standard triple therapy for rectal cancer?
Disease control OngoingThis study tests whether the immunotherapy drug dostarlimab alone can effectively treat people with a specific type of advanced rectal cancer (dMMR/MSI-H) that has not been treated before. About 154 participants will receive dostarlimab and be closely monitored. The goal is to se…
Matched conditions: NEOPLASMS, RECTAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Immunotherapy drug shows promise for untreated rectal cancer in chinese patients
Disease control OngoingThis study tests a drug called dostarlimab in 23 Chinese patients with a specific type of advanced rectal cancer (dMMR/MSI-H) that has not been treated before. The goal is to see if the drug can make the cancer disappear completely and stay gone for at least 12 months. Patients r…
Matched conditions: NEOPLASMS, RECTAL
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 18, 2026 12:13 UTC